Immune abnormalities in myelodysplastic syndromes.
نویسندگان
چکیده
The immune states of 52 patients with myelodysplastic syndromes classified according to the FAB criteria were studied. Serum electrophoresis and immunoelectrophoresis, direct Coombs test, and tests for organ and non-organ specific antibodies were performed. Twenty six patients had immunoglobulin abnormalities: six (11.5%) had monoclonal gammopathy; 17 (32.6%) had polyclonal increases in serum immunoglobulin; while in three (5.8%) immunoglobulin concentrations were decreased. The distribution of immunoglobulin abnormalities among the five myelodysplastic syndrome subtypes was fairly uniform. Results of direct Coombs test were negative in all cases. Organ specific antibodies were not detected in any of the patients tested, although two patients were found positive for antinuclear antibodies. The presence of immunoglobulin abnormalities indicates an involvement of the lymphoplasmatic system in myelodysplastic syndromes.
منابع مشابه
Immune pathology of myelodysplastic syndromes.
Myelodysplastic syndromes (MDS)are clinically characterized by morphological dysplasias of blood cells and cytopenias of variable combinations due to ineffective hematopoiesis (1). They often transform into acute myeloid leukemia (AML) as designated preleukemic syndromes. About 60% of cases with MDScarry a non-randomchromosomeabnormality such as -7, 7q-, -5, 5q-, 20qetc and/or complex abnormali...
متن کاملMyelodysplastic syndrome accompanied by Addison's disease and multiple autoimmune phenomena: steroid therapy resolved cytopenias and all immune disorders.
We report here a patient with myelodysplastic syndromes (MDS), which was complicated with several autoimmune disorders and asymptomatic immunologic abnormalities. An 82-year-old woman with refractory anemia (RA) rapidly developed thrombocytopenia with the appearance of symptoms such as purpura, fatigue, anorexia, and weight loss. Furthermore, clinical examinations revealed that she also had Add...
متن کامل[Recent advances in the treatment of myelodysplastic syndromes].
OBJECTIVES Myelodysplastic syndromes (MDS) are a group of clonal hematologic disorder, which combine ineffective hematopoiesis and evolution to acute myeloid leukemia. Significant progress has been made in the understanding of the disease pathogenesis, diagnostics and classification. Promising new agents and innovative therapeutic strategies are currently used. In this article we will review th...
متن کاملImmune mechanisms in the pathophysiology of cytopenia in myelodysplastic syndromes and the response to immunosuppression
haematologica | 2009; 94(4) | 449 | Myelodysplastic syndromes (MDS), first clearly defined as an entity by the pioneering studies of Bernard Dreyfus and others, have long been perceived as pre-leukemic hematopoietic stem cell abnormalities which cause bone marrow failure and ultimately transform to acute leukemia. The bone marrow failure, resulting in the transfusion dependence and neutropenic ...
متن کاملCytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
Karyotype is one of the main constituents of the International Prognostic Scoring System (IPSS) and revised-IPSS that are the cornerstones for the prognostication of patients with myelodysplastic syndromes (MDS). Del(5q), -7/del(7q), +8 and -Y are among the most extensively studied cytogenetic abnormalities in MDS. The same applies for normal karyotype. There are hundreds of other rare cytogene...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of clinical pathology
دوره 38 8 شماره
صفحات -
تاریخ انتشار 1985